The problem. Capture-based spatial methods faced a scale-versus-resolution bind: fine resolution over a large tissue meant an enormous number of capture spots, and most platforms couldn’t do both a big field of view and subcellular spot size. Mapping something as large and structured as a whole embryo, at high resolution, was out of reach.

The idea. Stereo-seq patterns DNA nanoballs on a chip at very high spatial density, giving a capture surface that is simultaneously large-area and subcellular in resolution. Applied to mouse organogenesis, it produced a spatiotemporal atlas — whole embryo sections across developmental stages — with both the breadth to see anatomy and the resolution to see cells.

Why it matters. This pushes the capture branch (Ståhl → Slide-seqV2) to large-field, high-resolution atlases, exactly the kind of tissue-scale mapping developmental and clinical spatial work needs. For the STU’s platform landscape, Stereo-seq marks how far capture-based resolution and field-of-view have jointly scaled. It’s also a reminder that “resolution” and “coverage area” are separate axes, and platforms differ on both.

Verdict. Foundational for large-scale, high-resolution capture-based spatial transcriptomics. Data volume and analysis burden are the practical costs of that scale. Read it as the atlas-scale endpoint of the capture branch — anatomy and single cells in one map.